Article Page

DOI: 10.31038/IGOJ.2020321

Abstract

Latent Genital Tuberculosis (LGTB) is commonly asymptomatic, and it is usually diagnosed during infertility investigations. The main objective of the present study was to establish the role of LGTB in causing unexplained infertility.

Material and method: 517 women, from January 2016- December 2018, at Calcutta Fertility Mission, had undergone DNA-PCR test (polymerase chain reaction) for screening of LGTB, then had had subsequent treatment with Anti-Tubercular Drugs (ATD) with or without laparoscopy. These patients were further classified as Group A and Group B based on their findings on laparoscopy to have early endometriosis or minor tubal defects or both. The Clinical pregnancy rate was calculated and analyzed among groups of women who were treated with ATD; treated with ATD and laparoscopy and those who were treated with estrogen-progestins for endometriosis.

Result: 28.6% of patients with apparently unexplained infertility were found to have LGTB and 31.76% of them had conceived following treatment with ATD. 71.4% of the patients who did not have LGTB had to be re-evaluated by laparoscopy. 35.64% patients in Group A and 34.15% patients in Group B, were diagnosed to have early endometriosis. Minor tubal defects on laparoscopy were found in as high as 43.56% of Group A patients and 29% in Group B. Hence the patients in Group A who had LGTB and had to be treated with ATD were seen to have quite higher prevalence of tubal defects compared to Group B and it has been seen to be statistically significant also (p value=0.003). 36.36% of Group A patients had conceived within 6 months of laparoscopy and 23.36% of women in Group B had achieved pregnancy.

Conclusion: LGTB is one of the major causes of apparently unexplained infertility and even the factors like early endometriosis or minor tubal defects are often associated with this condition and enhances the ill-effect causing infertility.

Keywords

Latent genital tuberculosis, Unexplained infertility, Laparoscopy, Pregnancy, Endometriosis, Tubal defect

Introduction

Unexplained infertility which amounts to about 30% of the infertile couple, can be defined as the lack of an obvious cause for a couple’s infertility and the inability to conceive after at least 12 cycles of unprotected intercourse for whom all the standard evaluations are normal. The veracity of ‘unexplained infertility’ term has been challenged by many clinicians and researchers and it has been emphasized that the assignment of the title to an infertile couple is much dependent on the quality and nature of the diagnostic tests performed [1,2]. According to the NICE  guidelines,  necessary  tests for unexplained infertility are semen analysis, assessment of ovulation and the luteal phase, and assessment of tubal patency by hysterosalpingogram or laparoscopy. However, there is controversy about the value of endometrial biopsy, ovarian reserve (Serum anti- mullerian hormone, antral follicle count), post-coital test and serum prolactin levels. The inability to find the specific cause of couples’ infertility does not mean that there is absolutely no cause for the disorder. Factors including lack of strong evidence, couples’ impatience for completion of standard protocols and dominance of Artificial Reproductive Technique (ART) treatment compared to other options in infertility clinics lead to diversity of clinical practice regarding unexplained infertility. Extensive research should be conducted on other possible causes of failed conception such as ovarian and testicular dysfunctions, sperm and oocyte quality, minor fallopian tube defects, endometrial receptivity, implantation failure and endometriosis [3,4]. Latent Genital Tuberculosis (LGTB) is a major health problem in many developing countries in Asia and Africa and has been proved to be responsible for a significant proportion of female infertility. It is asymptomatic in majority of the affected women and is diagnosed only during infertility work-up [5]. The most involved genital organs (whether solely or with other organs) have been seen to be fallopian tubes (63.84%), ovaries (46.15%), endometrium (38.46%) and the cervix (23.07%) in female genital tuberculosis but the involvement has not been documented in LGTB [6]. However, a few authors have reported the endometrium to be involved the most with as high as 60% in cases of infertility [7]. The present study was conducted to determine the role of latent genital tuberculosis in couples diagnosed with apparently unexplained infertility.

Material and Methods

This retrospective study was conducted at Calcutta Fertility Mission in Kolkata, India, from January 2016 to December 2018. The data were collected from a total of 517 patients as cases between 25-35 years of age, who had primary infertility which was apparently unexplained. These patients had normal ovulatory function and normal ovarian reserve, fallopian tubes appeared normal on hysterosalpingogram, their partners had normal semen parameters. They had undergone routine tests along with the DNA-PCR test with an endometrial aspirate on day 21 to day 24 of respective menstrual cycles (Table 1).

Table 1: Age of patients in groups.

 

Age

Total

p Value

Significance

25-30

31-35

PCR

POSITIVE

58 (29.74)

90 (27.95)

148 (28.63)

0.662

Not Significant

NEGATIVE

137 (70.26)

232 (72.05)

369 (71.37)

Total

195 (100)

322 (100)

517 (100)

 

 

Group A and B

Mild/Moderate Endometriosis

59 (33.52)

103 (35.03)

162 (34.47)

0.426

Not Significant

Tubal Defects

52 (29.55)

99 (33.67)

151 (32.13)

Both

65 (36.93)

92 (31.29)

157 (33.4)

Total

176 (100)

294 (100)

470 (100)

 

 

Pearson’s Chi Square test for Independence of Attributes.

517 patients were grouped initially as those who had LGTB (PCR positive) and who did not have LGTB (PCR negative). 148 (28.6%) patients were found to have LGTB and 369 (71.4%) of them were not affected (Table 2). These 148 patients were treated with Anti- tubercular drugs (ATD) for 6 months and subsequently 47 (31.76%) of them had conceived following the treatment.

Table 2: Patients of unexplained infertility with LGTB.

PCR

Frequency

Percent

Positive

148

28.6

Negative

369

71.4

Total

517

100.0

Hence in the said cohort there were 101 patients who could not conceive after being treated with ATD and 369 patients were PCR negative and had to be further re-evaluated for infertility. These women were grouped as Group A (101) (PCR negative after treatment with ATD) and Group B (369) (PCR negative). These patients were counselled for laparoscopy and based on the laparoscopy findings they were diagnosed to have either Stage 1 or Stage 2 endometriosis, or minor tubal defects and some had both early endometriosis and minor tubal defect.

On laparoscopy these patients with early endometriosis had one or two of the following features:

1. Endometriotic spots on pelvic organs and in POD

2. Flimsy adhesions in POD.

3. Pseudocavitations.

4. Peritoneal deficiency.

These patients were treated with estrogen and progesterone combination or with dienogest for 3-6 months for endometriosis and patients with minor tubal defects were corrected by laparoscopy. The post-treatment Clinical Pregnancy Rates (CPR) were calculated and analysed in all these groups (Table 3).

Table 3: Clinical Pregnancy in patients in Group A and B.

Clinical pregnancy

Group

Total

p Value

Significance

Mild/Moderate Endometriosis

Tubal Defects

Both

Group A

Pregnancy

No

26 (72.22)

28 (63.64)

16 (76.19)

70 (69.31)

0.528

Not Significant

Yes

10 (27.78)

16 (36.36)

5 (23.81)

31 (30.69)

Total

36 (100)

44 (100)

21 (100)

101 (100)

 

 

Group B

Pregnancy

No

94 (74.6)

82 (76.64)

108 (79.41)

284 (76.96)

0.650

Not Significant

Yes

32 (25.4)

25 (23.36)

28 (20.59)

85 (23.04)

Total

126 (100)

107 (100)

136 (100)

369 (100)

 

 

Pearson’s Chi Square test for Independence of Attributes.

Statistical Analysis

Categorical variables will be expressed as Number of patients and percentage of patients and compared across the 2 groups Pearson’s Chi Square test for Independence of Attributes. The statistical software SPSS version 20 will be used for the analysis. An alpha level of 5% has been taken, i.e. if any p value is less than 0.05 it will be considered as significant.

Ethical Consideration

The Ethical Committee of Calcutta Fertility Mission has given clearance for the retrospective study of a prospective database on 21/10/2019 (CFM/2019/029). Written informed consent has been obtained from all women who participated in the study.

Discussion

Management of infertile couples should always be individualized. The key variables like age, treatment history, costs and risks should be considered in selecting treatment plan of every couple. Over recent decades, the use of medically assisted reproduction (MAR) has increased enormously [8]. It is important to select couples who would actually benefit from MAR [9,10]. In couples with unexplained infertility the chance of a natural conception within 1 year is 30% or higher. MAR is no better than tailored expectant management (TEM) of 6–12 months, except in those who have gradually diminishing ovarian reserve [11,12]. Most often TEM is underutilised either due to failure in identifying couples who are eligible for TEM, or couples do not undergo expectant management for lack of advice by medical professional or impatience of the couple concerned.

Latent genital tuberculosis is rare in developed countries but is an important cause of subclinical chronic pelvic inflammatory disease and infertility in underdeveloped and developing countries. Previous literature show genital tuberculosis as a cause of infertility in 3-16% of women, varying to about 20% in India [13,14]. In the present study 28.6% of patients with apparently unexplained infertility were found to have LGTB and 31.76% of them had conceived following treatment with ATD. 71.4% of the patients who did not have LGTB had to be re-evaluated by laparoscopy along with those who could not achieve pregnancy even after treatment with ATD.

The relationship between endometriosis and infertility has been debated since years. Women with endometriosis tend to have a 2-10% lower monthly fecundity [15,16]. 25-50% infertile women are likely to have endometriosis which results in about 6-8% of the total population [17]. Several mechanisms have been proposed to explain the association between endometriosis and infertility which include distorted pelvic anatomy, endocrine and ovulatory abnormalities and altered humoral and cell-mediated functions in the endometrium. Major pelvic adhesions or peritubal adhesions that alter the tubo-ovarian relation, impair oocyte release from the ovary, inhibit ovum pickup, or impede ovum transport [18]. In our study 35.64% patients with unexplained infertility in Group A and 34.15% patients in Group B, were diagnosed to have early endometriosis. (Stage I and II).The overall prevalence of endometriosis in population‐based studies varies from 0.8% to 6%; however, in case of associated infertility, the prevalence seems to be considerably higher, ranging from 20% to 50%, but with significant variation over time periods and the age of patients [19-22].

In our previous study it has been stated that 846 out of 1726 (49%) women with unexplained infertility, were diagnosed to have minor tubal defects and were treated for the same by laparoscopy. The clinical pregnancy rate was about 27% following the treatment [23].

Similarly in the present study, we had detected minor tubal defects on laparoscopy in as high as 43.56% of Group A patients and 29% in Group B. Hence the patients in Group A who had LGTB and had to be treated with ATD were seen to have quite higher prevalence of tubal defects compared to Group B and it has been seen to be statistically significant also (p value=0.003). 36.36% of Group A patients had conceived within 6 months of laparoscopy and 23.36% of women in Group B had achieved pregnancy.

In the present study we had also found 20.79% women in Group A and 36.86% in Group B had both minor tubal defects and early endometriosis. Early endometriosis, minor tubal defects or even both of these conditions have been seen to be associated with a substantial number of patients with apparently “unexplained” infertility. A strong association of LGTB has been noticed with these factors also. All these etiological factors have been found to be statistically significant in Group A and Group B (p value=0.003) (Table 4).

Table 4: Other etiology of infertility in Group A and B.

Group A

Group B

Total

p Value

Significance

Etiology

Mild/Moderate Endometriosis

36 (35.64)

126 (34.15)

162 (34.47)

0.003

Significant

Tubal Defects

44 (43.56)

107 (29)

151 (32.13)

Both

21 (20.79)

136 (36.86)

157 (33.4)

Total

101 (100)

369 (100)

470 (100)

 

 

Pearson’s Chi Square test for Independence of Attributes.

Our patients with early endometriosis were treated with estrogen- progestins or with dienogest for 6 months primarily and none of them required surgical intervention. 27.78% women in Group A and 25.4% in Group B had conceived after the treatment and ovulation induction.

Estrogen-progestins with the lowest possible estrogen  dose should be chosen to combine optimal lesion suppression and thrombotic risk limitation. Progestins should be suggested in women who do not respond or manifest intolerance to estrogen-progestins [24]. According to Kitirat Techatraisak et al. dienogest has been seen to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and consequently, health-related quality of life [25]. Jacobson et al. in their study had shown laparoscopic resection or ablation of minimal and mild endometriosis enhances fecundity in infertile women [26].

After treatment of LGTB, early endometriosis and correction of minor tubal defects, 23.81% patients had spontaneous conception    in Group A and 20.59% of women in Group B had conceived after treatment of endometriosis and laparoscopy.

Conclusion

From the present study we can say that LGTB has a very important role in unexplained infertility and once detected and treated it can even yield spontaneous pregnancy. Persistence of infertility even after the treatment of LGTB, may be due to other associated problems like early endometriosis, minor tubal defects or both, which have also been in patients who did not have LGTB. These were undetected until they had undergone laparoscopy. There is strong possibility that presence of LGTB aggravates these conditions.

Acknowledgment

Mr. Souvik Dutta for management, analysis and interpretation of the data and Ms. Orphi Bhattacharya for preparation of manuscript.

Abbreviations: LGTB: Latent Genital Tuberculosis; ATD: Anti-Tubercular Drugs

References

  1. Gelbaya TA, Potdar N, Jeve YB, Nardo LG (2014) Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv 69: 109-115. [crossref]
  2. Johnson LN, Sasson IE, Sammel MD, Dokras A (2013) Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta- analysis. Fertil Steril 100: 704-711. [crossref]
  3. Hatasaka H (2011) New perspectives for unexplained infertility. Clin Obstet Gynecol 54: 727-733. [crossref]
  4. Okun N, Sierra S (2014) Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can 36: 64-83. [crossref]
  5. Suneeta Senapati, Kurt Barnhart (2011) Managing Endometriosis Associated Infertility. Clin Obstet Gynecol 54: 720-726. [crossref]
  6. Boubacar Efared, Ibrahim S Sidibé, Fatimazahra Erregad, Nawal Hammas, Laila Chbani, et al. (2019) Female genital tuberculosis: a clinicopathological report of 13 cases. Journal of Surgical Case Reports 3: 83.
  7. G. Angeline Grace, D. Bella Devaleenal, Mohan Natrajan (2017) IndianJ Med Res 145: 425-436.
  8. Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, Mouzon J de, et al. (2013) European IVF-Monitoring (EIM) Consortium for the European Society of Human Reproduction and Embryology (ESHRE)et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. HumReprod 28: 2318-2331. [crossref]
  9. Brandes M, Hamilton CJ, vanderSteen JO, Bruin de JP, Bots RS, et al. (2011) Unexplained infertility: overall ongoing pregnancy rate and mode of conception. Hum Reprod 26: 360-368. [crossref]
  10. VanGelovenN, VanderVeenF, BossuytPM, HompesPG, Zwinderman AH, et al. (2013) Can we distinguish between infertility and subfertility when predicting nRom W, Garay S.1996 Tuberculosis,1st edn., Little Brown, New York, USA.atural conception in couples with an unfulfilled child wish? HumReprod 28: 658-665.
  11. Custers IM, van Rumste MM, van der Steeg JW, van Wely M, Hompes PG, et al. (2012) Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management andimmediatetreatment. Hum Reprod 27: 444-450. [crossref]
  12. Nandi A, Homburg R (2016) Unexplained subfertility: diagnosis and management. The Obstetrician & Gynaecologist 18: 107-115.
  13. Sharma JB (2015) Current diagnosis and management of female genital tuberculosis. J Obstet Gynaecol India 65: 362-371. [crossref]
  14. Sughra Shahzad (2012) Investigation of the prevalence of female genital tract tuberculosis and its relation to female infertility: An observational analytical study. Iran J Reprod Med 10: 581-588. [crossref]
  15. Practice Committee of the American Society for Reproductive Medicine (2012) Endometriosis and infertility: a committee opinion. Fertility and sterility 98: 591-598. [crossref]
  16. Matthew Latham Macer, Hugh S. Taylor (2012) Obstet Gynecol Clin North Am 39: 535-549.
  17. Carlo Bulletti, Maria Elisabetta Coccia,Silvia Battistoni, Andrea Borini (2010) Endometriosis and infertility. J Assist Reprod Genet 27: 441-447.
  18. Holoch KJ, Lessey BA (2010) Endometriosis and infertility. Clinical obstetrics and gynecology 53: 429-438. [crossref]
  19. Abbas S, Ihle P, Köster I, Schubert I (2012) Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis‐related symptoms: findings from a statutory health insurance‐based cohort in Germany. Eur J Obstet Gynecol Reprod Biol 160: 79- 83. [crossref]
  20. Fuldeore MJ, Soliman AM (2016) Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross‐sectional survey of 59,411 women. Gynecol Obstet Invest. 82: 453-461. [crossref]
  21. Parveen Parasar, Pinar Ozcan, Kathryn L.Terry (2017) Endometriosis: Epidemiology, Diagnosis and Clinical Management. Curr Obstet Gynecol Rep 6: 34-41. [crossref]
  22. Haas D, Chvatal R, Reichert B, Renner S, Shebl O, et al. (2012) Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet 286: 667-70. [crossref]
  23. Chatterjee Siddhartha, Gon Chowdhury Rajib, Dey Sandip, Poddar Vishnu. Minor tubal defects (2010) The unnoticed causes of unexplained infertility. The Journal of Obstetrics and Gynecology of India 60: 331-336.
  24. Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, et al. (2016) Estrogen- progestins and progestins for the management of endometriosis. Fertil Steril 106: 1552-1571. [crossref]
  25. Kitirat Techatraisak, Andon Hestiantoro, Soon Ruey, Maria Jesusa Banal-Silao, Mee- Ran Kim, et al. (2019) Effectiveness of dienogest in improvingquality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real life clinical practice. BMC Women’s Health 19: 68. [crossref]
  26. Jacobson TZ, Duffy JM, Barlow D, Farquhar C, Koninckx PR, et al. (2010) Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 20: 1398. [crossref]

Article Type

Research Article

Publication history

Received: June 18, 2020;
Accepted: June 28, 2020;
Published: July 18, 2020;

Citation

Siddhartha Chatterjee, Bishista Bagchi, Arpan Chatterjee and Abira Datta (2020) Latent Genital Tuberculosis – A Possible Explanation for Unexplained Infertility. Integr Gyn Obstet J Volume 3(1): 1-4. DOI: 10.31038/IGOJ.2020321

Corresponding author

Dr. Siddhartha Chatterjee,
Calcutta Fertility Mission,
21 Bondel Road, Kolkata 700019,
India,
Tel: 9830387875